每周股票复盘：祥生医疗（688358）2025年限制性股票激励计划获通过

Core Viewpoint - Xiangsheng Medical (688358) experienced a decline in stock price, closing at 32.62 yuan, down 3.61% from the previous week, with a current market capitalization of 3.658 billion yuan [1][2] Company Announcement Summary - The second extraordinary general meeting of shareholders for Xiangsheng Medical was held on October 17, 2025, with 28 shareholders present, representing 82,487,873 voting shares, accounting for 73.7323% of the total voting rights [1][2] - The meeting approved three special resolutions related to the 2025 Restricted Stock Incentive Plan, with 99.8782% of the votes in favor, and no resolutions were rejected [1][4] - Shanghai Tongli Law Firm provided legal opinions confirming the legality of the meeting's procedures and resolutions [2][4] Insider Trading Self-Examination Report - A self-examination report indicated that only one incentive object engaged in stock trading within six months prior to the announcement of the incentive plan, and this individual claimed the trading was based on public market information [2][4] - The company confirmed that there were no incidents of insider information leakage or misuse during the planning process [2][4]